GOLDMAN SACHS GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for INDIVIOR PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (INDV)

Filing manager: GOLDMAN SACHS GROUP INC
Reporting owner: THE GOLDMAN SACHS GROUP, INC.
Security: INDIVIOR PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share
Symbol: INDV
Shares outstanding: 123,876,924 shares
Disclosed shares: 3,592,431 shares
Ownership percentage: 2.9%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2026, 10:30:40 UTC
Event date: 31 Dec 2025
Previous filing: 12 Nov 2025
SEC filing: View on sec.gov

Key filing fact

GOLDMAN SACHS GROUP INC disclosed 2.9% ownership in INDIVIOR PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (INDV) on 31 Dec 2025.

Key facts

GOLDMAN SACHS GROUP INC filed SCHEDULE 13G/A for INDIVIOR PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (INDV).
Disclosed ownership: 2.9%.
Date of event: 31 Dec 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	2.9%	3,592,431	0	3,592,396	Name: Veronica Mupazviriwo	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	2.9%	3,592,431	0	3,592,396	Name: Veronica Mupazviriwo	Attorney-in-fact

CIK / CUSIP context first

Broader feeds